Saturday July 5th
 
 
 


UNITED STATES - 263 news CANADA - 37 news UNITED KINGDOM - 36 news GERMANY - 34 news DENMARK - 24 news FRANCE - 21 news AUSTRALIA - 16 news SWEDEN - 16 news JAPAN - 11 news NETHERLANDS - 9 news SWITZERLAND - 7 news ISRAEL - 7 news NORWAY - 6 news BELGIUM - 3 news ICELAND - 3 news AUSTRIA - 2 news SPAIN - 2 news IRELAND - 2 news INDIA - 2 news FINLAND - 1 news ITALY - 1 news PORTUGAL - 1 news TAIWAN - 1 news Most active countries (last 30 days) [enlarge]

 

  Next
[ 45 ]
[ 40 ]
[ 38 ]
[ 35 ]
[ 34 ]
[ 23 ]
[ 22 ]
[ 22 ]
[ 22 ]
[ 20 ]
[ 20 ]
[ 19 ]
[ 18 ]
[ 18 ]
[ 17 ]
[ 17 ]
[ 17 ]
[ 17 ]
[ 16 ]
[ 15 ]
Most active sources (last 90 days)
 
-
-
[Interview]
 

::: China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
Shanghai Shining Biotechnology, China-Biotics plans, Company undertakes, forward-looking statements, distribution of probiotics dietary supplements, live microbial nutritional supplements, Web site, health product, flagship product profits, Shining brand stores
::: LinkMed acquires world leading company in the transplantation sector
larger transplantation company, Olerup SSP, portfolio company Absorber, transplantation sector, world leading company, larger company, Olle Olerup, Olerup SPP, successful transplantation, transplantation area
::: Acquisition of leading dermatological & wound care brands, $48 million (£24.2 million) financing and £3.9 million institutional placing
York Pharma, topical wound infections, Acquisition of leading dermatological, wound care brands, sales of Flammazine, Acquisition of the current sales, leading brands, dermatological brands, specialist dermatology sales, leading dermatological/wound care products
::: Alsace BioValley announces EUR 11 million project for life sciences building hosting research, scientific expertise and services
Alsace Biovalley cluster, Alsace Region, go-getting Alsace attitude, advantages of Alsace, capital of the Alsace, life sciences industry, regional services, center of excellence combining services, Platform Center serving research, creation of industry partnerships
::: Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
Bentley stockholders, Bentley manufactures, Bentley Pharmaceuticals Ireland, Bentley API, Bentley Park, number of Bentley options, Bentley Board of Directors, merger agreement, Merger Consideration, Beryllium Merger Corporation

search powered by PERTIMM: 'the discover engine'